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Voltage-gated potassium channelThe human ether-à-go-go related gene (hERG) potassium channels are located in the myocardium cell
membrane where they ensure normal cardiac activity. The binding of drugs to this channel, a side effect
known as drug-induced (acquired) long QT syndrome (ALQTS), can lead to arrhythmia or sudden cardiac
death. The hERG channel is a unique member of the family of voltage-gated K+ channels because of the long
extracellular loop connecting its transmembrane S5 helix to the pore helix in the pore domain. Considering
the proximal position of the S5-P linker to the membrane surface, we have investigated the interaction of its
central segment I583–Y597 with bicelles. Liquid and solid-state NMR experiments as well as circular dichroism
results show a strong afﬁnity of the I583–Y597 segment for the membrane where it would sit on the surface
with no deﬁned secondary structure. A structural dependence of this segment on model membrane
composition was observed. A helical conformation is favoured in detergent micelles and in the presence of
negative charges. Our results suggest that the interaction of the S5-P linker with the membrane could
participate in the stabilization of transient channel conformations, but helix formation would be triggered by
interactions with other hERG domains. Because potential drug binding sites on the S5-P linker have been
identiﬁed, we have explored the role of this segment in ALQTS. Four LQTS-liable drugs were studied which
showed more afﬁnity for the membrane than this hERG segment. Our results, therefore, identify two possible
roles for the membrane in channel functioning and ALQTS.iversité du Québec à Montréal,
da H3C 3P8. Tel.: +1 514 987
tte).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
HERG (human ether-à-go-go-related-gene) potassium channels are
essential for the normal electrical activity of the heart. Located in the
myocardium cell membrane, the structure of these voltage-gated K+
channels (VGK) has never been determined experimentally. Homology
models of the hERG K+ channel have been proposed based on its
primary sequence and the X-ray structure of various bacterial K+
channels [1–3]. The predicted structure consists of four monomeric
subunits, each containing six transmembrane spanning helices S1–S6
[4]. The ﬁrst four helices (S1–S4) comprise the primary voltage sensor
while S5 and S6 form the pore domain. The K+ selectivity ﬁlter and a
small pore helix (P) involved in inter-subunits contacts are found on the
extracellular loop that links S5 to S6. The loops from each monomer
meet into the pore to form the selective K+ doorway of the channel [5].
Inherited mutations in the hERG gene can cause the long QT
syndrome (LQTS), a cardiac repolarization disorder that predisposes
individuals to ventricular arrhythmia that can lead to sudden death.
However, A(cquired)LQTS can also be induced by the blockage of thehERG channels by prescription drugs. This side effect has resulted in
signiﬁcant labelling restrictions or drug withdrawal from the market
by regulatory agencies worldwide [6,7]. It is now routine practice in
the pharmaceutical industry to test compounds for hERG-channel
activity, and LQTS is a common reason for drug failure in early
preclinical safety trials [8].
The problem of ALQTS is correlated with the wide spectrum of
hERG blockers. Several classes of structurally different therapeutic
molecules such as antibiotics, antihistamines, antipsychotics and
antiarrhythmics have LQTS side effects [9–12]. Electrophysiology and
in silico studies show that most hERG-channel blockers would exert
their activity by binding one or several sites located in the pore
domain. This region is composed of S5 and S6 which inner cavity is
lined by aromatic and polar residues that permit hydrophobic,
electrostatic and polar interactions with a wide range of compounds
[1,4,13–16]. Tyr652 and Phe656 located on S6 are especially important
for the binding of many drugs [1,15–19]. The role of the extracellular
S5-P linker has also been pointed out with residues such as Ser620 [14],
Thr623, Ser624 and Val625 [16] being involved in the binding of LQTS-
prone drugs. Toxins such as ErgToxin and BeKm-1 are known to bind
to this region of hERG while they do not bind to other members of the
VGK family [20,21]. However, some toxins such as agitoxin and
charybdotoxin are known to bind the S5-P loop of VGK channels but
not the hERG.
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of its long extracellular loop connecting S5 to the pore helix, i.e. 43
amino acid residues vs. 12–23 residues in most K+ channels [22,23].
Liu et al. [24] showed that mutations in the 15 amino-acid residue
central segment I583–Y597 of the S5-P linker lead to hERG channel
dysfunction. They thus suggested its role in the degree of inactivation
and K+ selectivity [25]. Their analysis of these mutations also
suggested a helical periodicity of I583–Y597 [24]. Recent nuclear
magnetic resonance (NMR) structural work performed on this
segment also showed a helical conformation in sodium dodecylsulfate
(SDS) and dodecylphosphocholine (DPC) micelles [23,26]. A model
was proposed in which the NH2-terminal would be located close to
the pore entrance, with a 20 Å 583–597 helix that would be
sufﬁciently long to interact with the voltage-sensing domain [24].
From these studies, it was suggested that the I583–Y597 extracellular
segment of the hERG would undergo dynamical structural changes,
approaching the pore entrance to participate to the function of the
channel outer mouth [23,25]. It is clear that this long hERG S5-P linker
is a critical region of the channel, therefore it is of great importance to
identify its dynamic and structural role in the channel function.
Considering the proximal position of the S5-P linker to the
membrane surface, the aim of this work was to investigate the
interaction of the I583–Y597 segment of hERGwithmodel phospholipid
membranes. To the best of our knowledge, no information regarding
its interactions with membrane has been published. Moreover, to
explore the role of this S5-P linker moiety on the drug-induced LQTS,
we have also studied its interaction with LQTS-liable drugs. This was
done by combining liquid- and solid-state NMR and using bicelles as
model biomembranes. Bicelles are generally composed of dimyris-
toylphosphatidylcholine (DMPC) and dihexanoylphosphatidylcholine
(DHPC) in a molar ratio (q) which determines the membrane size,
shape and properties [27–29]. By adjusting the q ratio, fast-tumbling
and magnetically aligned bicelles (qN2.3) can be prepared, therefore
these membranes are tunable for liquid- and solid-state NMR
experiments, respectively. Similarly to natural membranes, bicelles
have a planar surface and their lipids are in the liquid-crystal phase.
Four drugs with reported QT prolongation effect were selected for
this study because of their different structures, octanol–water
partition coefﬁcients (logP), and pharmacological classes, as shown
in Table 1. Bepridil, a calcium antagonist initially developed as anTable 1
Structures and logP values of the studied cardiotoxic drugs.
Drug logP Structure
Bepridil 5.33
Cetirizine 2.98
Diphenhydramine 3.44
Pentamidine 1.32antianginal agent, was withdrawn from the market for causing
Torsades de Pointes (TdP) [30–32]. Diphenhydramine and cetirizine
are respectively ﬁrst- and second generation antihistamines that
showed inhibition of hERG channels [33–35], while pentamidine is an
antiprotozoal agent reported to cause QT prolongation and TdP when
given in intravenous form [36–38].
Using 1H liquid-state NMR with Pulsed Field Gradient (PFG) self-
diffusion measurements, the membrane afﬁnity of I583-Y597 and the
drugs, as well as the drug/segment association are evaluated.
Saturation transfer difference (STD) 1H NMR experiments are used
to determine the location of the hERG segment in the membrane.
Two-dimensional 1H NMR and circular dichroism spectra provide
structural data on the peptide in water, bicelles and various detergent
micelles. Finally, solid-state 31P and 2H NMR are employed to probe
the effect of the peptide and the cardiotoxic drugs on the polar and
hydrophobic regions of the membrane, respectively.
2. Materials and methods
2.1. Materials
The hERG extracellular linker segment with sequence IGWLHNL-
GDQIGKPYwas synthesized by GenScript Corporation (Piscataway, NJ,
USA) with N95% purity. Protonated and deuterated dimyristoyl- and
dihexanoylphosphatidylcholine (DMPC, DMPC-d54, DHPC, DHPC-d22),
dimyristoylphophatidylserine (DMPS), dodecylphosphocholine (DPC),
1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine (lyso-myristoyl-
phosphatidylcholine, LMPC) and 1-myristoyl-2-hydroxy-sn-glycero-3-
phosphoglycerol sodium salt (lyso-myristoylphosphatidylgycerol,
LMPG) were purchased from Avanti Polar Lipids (Alabaster, AL, USA)
while hexamethyldisilane (HMDS) and deuterium-depleted water,
deuterated sodium dodecylsulfate (SDS-d25), pentamidine isothionate,
bepridil, cetirizine and diphenhydramine hydrochlorides were
obtained from Sigma Aldrich (Oakville, ON, Canada) and used without
further puriﬁcation. Deuterium oxide (D2O) was purchased from CDN
Isotopes (Pointe-Claire, QC, Canada).
2.2. Sample preparation
2.2.1. Nuclear magnetic resonance
Bicelles were prepared by mixing freeze-dried DMPC and DHPC
with the desired long-to-short-chain (q) ratio in aqueous solution,
with or without hERG segment, and submitted to a series of three
freeze (liquid N2)/thaw (50 °C)/vortex shaking cycles until a
transparent non-viscous solution was obtained. Hydration percen-
tages (weight/weight) were 96% for high-resolution NMR and 80% for
solid-state NMR, and q ratios were as follows: q=0.5 for both
translational diffusion and saturation transfer difference measure-
ments, q=1 for chemical shift assignment and analysis, and q=3.5
for solid-state NMR experiments. Total lipid/peptide (L/P) molar
ratios of 25:1 and 100:1 were used for solid-state NMR, and 50:1 for
high-resolution 1H NMR. In all NMR experiments the peptide
concentration was 5 mM and the surfactant concentration was, thus,
maintained well above the critical micelle concentration (CMC) of
DHPC in the bicelle mixture (15 mM) [39]. The same sample
preparation was applied to SDS micelles. Because this segment is
believed to be dynamic and possibly involved in the K+ channel
function, deionized water (pH=5.5) was used to avoid salt
interference [23]. 1H diffusion NMR experiments were carried out in
D2O while all high-resolution NMR experiments were done using 10%
D2O. All two-dimensional NMR experiments were carried out using
lipids and SDS with deuterated acyl chains to minimize the
contribution of the lipid resonances to the 1H NMR spectra. Oriented
bicelles for solid-state 2H NMR were prepared with DMPC-d54 in
deuterium-depleted H2O.
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Bicelles and micelles were prepared as described above. Bicelles
containing DMPS (Bicelles/PS) were made by substitution of 25% of
DMPC with the negatively charged DMPS. For all samples, a hydration
percentage of 99%was employed. The concentration of hERG I583–Y597
segment was kept to 0.13 mg/ml (76 μM) while lipid or surfactant
concentrations were 33 mM (bicelles), 22 mM (Bicelles/PS), 30 mM
(DHPC), 15 mM (DPC, LMPC, LMPG). All lipid or surfactant concentra-
tions were thus kept above their CMC [39,40]. The surfactant/peptide
molar ratio was 200:1 to provide an appropriate micelle:peptide
stoichiometry that limits possible peptide aggregation. In the case of
bicelles (q=1), a total lipid-to-peptide molar ratio of 600:1 was
employed to ensure that at least two bicelles were available per I583–
Y597 segment in the sample. This can be assessed knowing
concentration of DMPC and DHPC, the q ratio and the surface area
of phosphatidylcholines [41].
2.3. Solution-and solid-state NMR
All spectrawere recorded on a hybrid liquid/solid-state Varian Inova
Unity 600 (Varian, Walnut Creek, CA, USA) spectrometer operating at
frequencies of 599.95 MHz for 1H, 246.86 MHz for 31P and 92.125 MHz
for 2H. The 1H chemical shifts were internally referenced by adding a
small amount of 2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS) set
to 0.0 ppm. All 31PNMRspectrawere externally referencedwith respect
to the signal of 85% phosphoric acid set to 0 ppm.
2.3.1. Pulsed-ﬁeld gradient (PFG) diffusion experiments
1H NMR self-diffusion measurements at 25 °C were performed
with a double-resonance 3-mm indirect z-gradient probe using the
water-suppressed LED pulse sequence (water-sLED) [42]. A hard 90o
pulse of 5.5 μs was used. The gradient pulse duration δ was 6 ms and
diffusion times (Δ) were varied between 100 and 150 ms to ensure
that the echo intensities were attenuated by at least 80%. 24000 data
points were obtained and typically 48 scans were acquired for each
selected gradient strength with a recycle delay of 5.0 s. A complete
attenuation curve was obtained by measuring 15 gradient strengths
which were linearly incremented between 2.1 and 31.5 G/cm.
Translational diffusion coefﬁcients (DS) were calculated using the
following equation [42]:
A Gð Þ = A 0ð Þ exp − γδGð Þ2 Δ−δ= 3ð ÞDS
h i
ð1Þ
where A(G) is the echo amplitude, γ is the 1H gyromagnetic ratio. The
gradient strength was calibrated using back calculation of the coil
constant from a measurement of the diffusion constant of H2O traces
in D2O using DS=1.9×10−5 cm2/s at 25 °C [43].
2.3.2. Saturation transfer difference (STD) experiments
The STD experiments consisted of a train of 50 ms Gaussian
selective pulses separated by 1 ms delays and followed by a WET
water suppression and detection [44–46]. The saturation frequencies
were alternated between the resonance to be saturated
and −25 ppm. The Gaussian pulses were applied with radio-
frequency ﬁeld strength of 120 Hz and saturation times were varied
between 250 ms and 5 s. The recycle delay was 3 s.
2.3.3. High-resolution 1H two-dimensional experiments
1H total correlation spectroscopy (TOCSY) spectra were recorded
with a 90o pulse of 5.5 μs, and spin-lock times of 25, 50 and 100 ms
withMLEV17 spin-lock ﬁelds of 15 kHz [47]. A spectral width of 8 kHz
was used in both dimensions with 512 and 1024 complex data points
in the indirect and direct dimensions, respectively. 16 transients were
accumulated with a repetition delay of 1 s. Two-dimensional nuclear
Overhauser spectroscopy (NOESY) spectra [48,49] were recordedusing a pulse length of 5.5 μs with mixing times varying from 100 to
750 ms. A spectral width of 8 kHz was used in both dimensions with
1024 data points in F2 and 512 increments in F1. A total of 16
transients were recorded with a repetition delay of 1 s.
2.3.4. Solid-state NMR experiments (SS-NMR)
Solid-state NMR experiments were carried out using a 4-mm
broadband/1H dual-frequency magic-angle-spinning probehead. 31P
NMR spectra were recorded using a phase-cycled Hahn echo pulse
sequence with gated broadband proton continuous wave decoupling
at a ﬁeld strength of 50 kHz [50]. The 90o pulse length was 5 μs, the
interpulse delays were 30 μs and typically 4800 scans were acquired
with a recycle delay of 3 s. 2H NMR spectra were obtained using a solid
echo pulse sequence [51] with a 90o pulse length of 3 μs, an interpulse
delay of 45 μs and repetition delay of 500 ms. At least 8000 data points
were obtained and typically 5000 scans were acquired. The quality of
the bicelles' magnetic orientation with or without the peptide was
sufﬁcient to enable the direct measurement of quadrupolar splittings
on the 2H spectra with no de-Pakeing.
2.3.5. Data processing
Diffusion, STD and SS-NMR data were processed using matNMR
[52]. High-resolution 2D NMR spectra were processed using the
NMRPipe package [53] and analyzed with the software NMRView for
chemical shift assignment and NOE calibrations [54].
2.3.6. Circular dichroism (CD) spectropolarimetry
CD analyses were performed on a JASCO J-815 spectrometer (Jasco
Inc., Easton, MD, USA) at ∼23°C. Data were collected using a 1-mm
100 QS cuvette over the wavelength range 190–250 nm and with a
resolution of 0.2 nm, a bandwidth of 1 nm, and a response time of
0.5 s. The signal was averaged over 5 scans with blank subtraction of
the lipid or surfactant suspension. In order to estimate the contribu-
tions of different structural elements, CD spectra were deconvoluted
using DICHROWEB and the SELCON3 or CONTIN-LL algorithms [55].
3. Results
3.1. Interaction of I583–Y597 with model membranes
3.1.1. Does this extracellular linker segment bind even weakly to
the membrane?
The central segment I583–Y597 of the S5-P linker of the hERG
channel displays a strong amphipathicity, therefore its potential
binding to the membrane needs to be addressed. As a ﬁrst step, we
have recorded 1H NMR spectra of this peptide in water and in the
presence of membrane mimetic milieus. Initially, TOCSY spectra (not
shown) were acquired to assign the 1H chemical shifts of the hERG
segment in water, bicelles and SDS micelles. The chemical shift values
are shown as supplementary material.
The 1D 1H NMR spectra show major changes for the amide and
aromatic regions when I583–Y597 is in deuterated bicelles (Fig. 1B) and
SDS-d25 micelles (Fig. 1C). In these conditions resonances are shifted
and considerably broadened as compared to the peptide in water
(Fig. 1A). This most likely results from a reduced mobility of the
peptide upon binding to large bicellar or micellar objects.
In order to quantify the afﬁnity of this hERG segment for the
membrane, we have determined the fraction of peptide bound to the
membrane. This was done by measuring the self-diffusion coefﬁcients
of the peptide in H2O and in the presence of bicelles (q=0.5) by 1H
NMR using pulsed ﬁeld gradient stimulated echo (PFGSTE) experi-
ments [46,56–58]. If the hERG segment is in rapid exchange on the
NMR timescale between the free and the bound states and assuming a
two-site model as proposed by Stilbs [59], the diffusion coefﬁcient
(Dobs) of the bicelle-associated peptide will be an average of diffusion
coefﬁcients for the free (Dfree) and bound (Dbound) states. In our study,
Table 2
Translational diffusion coefﬁcients of bicelles (q=0.5), hERG I583–Y597 and cardiotoxic
drugs used to calculate the fraction of bound peptide and drugs.
System Dobs (×10−10 m2∙s−1)
in water with Bicelles with I583–Y597 withBicelles/I583–Y597
Bicelles 0.29 – – –
hERG I583–Y597 1.72 0.31 – –
98%
Bepridil 3.82 0.28 3.43 –
100% 18% –
Cetirizine 3.97 0.33 3.70 –
99% 13% –
Pentamidine 3.57 0.37 3.27 –
97% 16% –
Diphenhydramine 4.94 0.42 4.68 0.38
97% 9% 98%
Fig. 1. Amide and aromatic regions of the 1H NMR spectra of hERG I583–Y597 in
(A) water, (B) bicelles (DMPC-d54/DHPC-d22, q=1), and (C) SDS-d25 micelles (lipid or
surfactant-to-peptide molar ratio of 50:1).
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Dbound to the diffusion coefﬁcient of the bicelles in water. Following
such a model, the percentage of peptide bound to the membrane can
be calculated as follows:
Dobs−Dϕfree
Dbound−Dϕfree
× 100 ð2Þ
This model can also be applied to assess the binding of a drug with a
membrane or a peptide.
Dϕfree is the corrected free diffusion coefﬁcient because in a bicelle
environment, the diffusion of the free hERG peptide (or drug) in the
aqueous solution can be hindered by the actual presence of the
bicelles. It is thus essential to correct Dfree by introducing an
obstruction factor A that can be deﬁned, for spherical objects,
according to the following equation:
A = 1 = 1 + 0:5ϕð Þ ð3Þ
where ϕ is the volume fraction of the obstructing particles. A factor A
of 0.935 can be calculated for a 14%w/w bicelle solution at 20 °C using
a spherical model as proposed by Gaemers and Bax [60]. Because a
radius of 43 Å is predicted for bicelles with q=0.5 and a bilayer
thickness of ∼40 Å [61], we have approximated the bicelles as
spherical objects and used this correction factor in our diffusion
measurement calculation as was done for the neuropeptide met-
enkephalin [57]. Since there are no analytical expressions to calculate
obstruction factors for discoidal objects, the best approximation for
which an analytical expression exists would be spheroids [60,62],
leading to an obstruction factor of 0.925. The commonly used
spherical approximation, thus, appears to be excellent for isotropic
bicelles with q=0.5 as used in our study.
The value of Dobs used in the calculations was the average of the
diffusion coefﬁcients obtained for three peptide resonances. Although
the diffusion coefﬁcient of bicelles can be measured with the PFGSTE
experiment from the signals of DMPC/DHPC directly, it can also bemeasured more accurately and conveniently from the signal of a small
amount of a hydrophobic probe molecule known to be completely
partitioned within the hydrophobic core of the bicelles. Indeed, in the
case of bicelles with low q ratios, the lipids are rapidly exchanging
between the solution and themicelle-like object [63]. As a consequence,
the apparent diffusion coefﬁcient obtained directly from lipid signals is
usually from 5% to 10% higher than the actual diffusion coefﬁcient of
bicellesdetermined from thediffusionof theprobemolecule [56]. In this
work, a small amount of hexamethyldisilane (HMDS) was added to the
bicellar samples and its resonance used to measure the diffusion of the
whole bicelle. HMDS has been widely used for this purpose in diffusion
studies of micellar and bicellar systems [56,59].
Table 2 presents the diffusion coefﬁcients measured for pure
bicelles, free andmembrane-associated I583–Y597 peptide as well as its
percentage of association to the bicelles as calculated from equa-
tion (2). All the plots of the normalized natural log signal intensity
versus squared gradient strength G2 were linear (not shown),
consistent with a fast-exchange scenario (or a single-state case).
This also indicates that there is no inﬂuence of intermolecular NOEs
on the diffusion results [64,65]. The translational diffusion coefﬁcients
for the bicelles are in good agreement with the values reported in the
literature [46,63]. Our results show that 98% of the peptidewould bind
to the model membranes at the lipid/peptide (L/P) molar ratio
studied (100:1). This constitutes the extreme case of the model
presented in equation (2) in which the association equilibrium is
displaced towards a bound state, i.e. a single-state model.3.1.2. Is the membrane perturbed by the hERG segment?
Considering the strong afﬁnity of the I583–Y597 segment of the
extracellular hERG loop, we have examined its effect on the phospho-
lipid membrane. 31P and 2H SS-NMR experiments are well-established
techniques to study the effect of peptides or drugs onmodel and natural
membranes. The high NMR sensitivity and 100% natural abundance of
the 31P isotope aswell as the presence of a single phosphorus nucleus in
the phospholipid headgroup allow exploiting 31P NMR to obtain
valuable information on the polar region of lipid membranes [66]. The
hydrophobic region on the other hand can be studied by 2H SS-NMR
using phospholipids with deuterated acyl chains. The quadrupolar
interaction is highly sensitive to motions in the bilayer, thus perturba-
tions of the hydrophobic core can be probed [67,68].
Fig. 2A presents the 31P SS-NMR spectra of DMPC-d54/DHPC
bicelles with andwithout the hERG peptide at 37 °C. These spectra are
typical of well-oriented bilayers with the normal perpendicular to the
direction of the magnetic ﬁeld. As assigned in previous work [27], the
upﬁeld resonance corresponds to the long-chain DMPC whereas
DHPC resonance appears at the downﬁeld side of the spectrum. This
can be explained by the reorientation or fast lateral diffusion of the
short-chain phospholipids on the highly curved region formed by the
Fig. 3. Quadrupolar splitting for different deuteron positions along DMPC-d54 acyl
chains in bicelles with and without hERG I583–Y597 segment (q=3.5, lipid-to-peptide
molar ratio of 100:1).
Fig. 2. (A) 31P and (B) 2H SS-NMR spectra of DMPC/DHPC bicelles (q=3.5) without
(solid line) and with (dashed line) hERG I583–Y597 at 37 °C with a lipid-to-peptide
molar ratio of 100:1.
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Fig. 2A shows that the hERG peptide has an effect on both DMPC and
DHPC resonances in bicelles at a L/P ratio of 100:1 as seen by changes
in the phospholipid chemical shifts, i.e.−5.91 to−4.53 ppm for DHPC
and −12.47 to −9.75 ppm for DMPC. These changes could be
explained by an effect of Ile583–Tyr597 on the lipid bicelle dynamics,
to which could be superimposed a deshielding effect of charged or
aromatic moieties in the phosphorus atom vicinity. A broadening of
the phospholipid resonances is also observedwhen the hERG segment
is added to the bicelles, with an additional upﬁeld shoulder on the
DMPC resonance. This peak broadening could result from a greater
distribution in bicelle orientation in the presence of the peptide
(mosaic spread) [72]. A strong perturbation of the headgroup region
of the membrane is thus evidenced and this effect was even more
substantial at an L/P ratio of 25:1 where the bicelle morphology
appeared to be destroyed (data not shown).
The 2H spectra of DMPC-d54 bicelles at 37 °C with and without the
Ile583–Tyr597 are shown in Fig. 2B. Again, these spectra are typical of
bicelles with their lipid bilayer normal oriented perpendicularly to the
magnetic ﬁeld direction [27,28]. Well-deﬁned doublets can be
attributed to most of the deuterons along the lipid acyl chain, with
the innermost doublet ascribed to the terminal CD3 and the largest
quadrupolar splitting to CD2 attached to the glycerol backbone near
the polar–apolar interface. The bicelle orientation is preserved when
the hERG peptide is incorporated in an L/P ratio of 100:1. This is not
the case for high segment proportions (L/P=25:1) where the bicelle
orientation is totally lost (not shown). The resolution of the doublet
for the various deuterium positions is decreased when the hERG
peptide interacts with the bicelles. This could be attributed to an
increase in mosaic spread of bicelle orientation, as possibly suggested
by 31P NMR, or changes in transverse relaxation.
To better understand the effect of the hERG segment on the
hydrophobic core of the bilayer, we have plotted the quadrupolar
splitting (ΔνQ) values along DMPC acyl chains. Changes in ΔνQ values
allows determination of variations in the lipid chain order [67]. Themeasured ΔνQ values shown in Fig. 3 display signiﬁcant changes upon
addition of the hERG segment to the bicelles. On average, this peptide
decreasesΔνQ values by∼10% in the characteristic plateau region closer
to the headgroup for an L/P ratio of 100:1, while C-D2 bonds deeper in
the bilayer are weakly affected. Although this difference of perturbation
along the acyl chains suggests a non-transmembrane orientation of the
peptide, the center of the bilayer is intrinsically disordered, thus less
sensitive to perturbations. Therefore the orientation of hERG I583–Y597 in
the bicelles has been ascertained by conducting additional NMR
experiments described in the next section.
3.1.3. Does the hERG I583–Y597 adopt a preferred orientation with respect
to the membrane?
Both the liquid-state NMR translational diffusion measurements and
SS-NMR experiments presented in the preceding sections indicate a
strong interaction of the hERG extracellular linker segment with the
membrane. The 31P and 2H SS-NMR experiments show that the
membrane is strongly perturbed and it isworthwhile to examinewhether
the peptide adopts a preferred orientation in the bilayer. For this purpose,
we have carried out STD experiments [44] on bicelles in the presence of
hERG Ile583–Tyr597. In these experiments, speciﬁc lipid resonances are
saturated and the effect of this saturation on the hERG segment
resonances is monitored. More speciﬁcally, we have saturated lipid
signals from the headgroup (choline), interface (glycerol) and hydropho-
bic regions (terminal methyl) and monitored the variations in the
saturation transfer build up and maximum values for different residues
along the peptide. It was thus possible to assess its position inside the
membrane, as was done by Wang, Lind and colleagues [46,73]. DMPC/
DHPC-d22 bicelles were employed for STD experiments in order to probe
the peptide penetration in the planar section of the bilayer and minimize
contacts with high-curvature regions.
Fig. 4 shows the saturation transfer curves of the HN protons for
Trp585, Asn588, Asp591, Ile593, Lys595 and Tyr597 when the choline,
glycerol and terminal methyl groups are saturated. These residues
were chosen so as to span the complete length of the peptide. In all
cases, the saturation transfers are efﬁcient with maximum plateau
values close to 0.3. These results are consistent with the previously
determined scenario in which the peptide is strongly bound to the
bilayer [45]. In effect, the saturation transfer will increase as the
equilibrium between the bound and free states is displaced towards
Fig. 4. Observed STD curves of amide protons for selected residues of hERG I583–Y597 segment in bicelles when choline (○), glycerol (■) or terminal methyl (Δ) resonances of DMPC
are saturated.
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(Trp585 and Tyr597), the transfer from the lipid terminal methyl group
is very weak or null and maximum to the choline protons. Note that
for both these residues, the choline resonance at 3.25 ppm falls close
to the Hβ resonances which could be directly saturated. Therefore, it is
important to assess the penetration of the residue in themembrane by
comparing saturation transfers from three different lipid sites. Should
one of these saturation curves be overestimated, the two other wouldhold. For the amide proton of residues 588, 591, 595 and 597 the
maximum saturation transfer takes place with the glycerol position,
whereas the transfer from the lipid choline group decreases when
going from Asn588 to Lys595 then increases for Tyr597. Ile593 shows the
highest saturation transfer from the choline headgroup. The satura-
tion transferred from the lipid methyl groups remains constant for
central residues 588 and 591, decreases for Ile593 and is null for the
terminal Tyr597.
Fig. 5. Circular dichroism spectra of hERG I583–Y597 in H2O (pH=5.5) and in various
membrane mimetic environments: DMPC/DHPC bicelles and bicelles with 25 mol%
DMPS (q=1), DHPC, DPC, LMPC and LMPG micelles.
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peptide does not span the membrane and remains in the headgroup
region in the vicinity of the glycerol interface. It can be tentatively
proposed that the central part of the peptide is buried deeper in the
membrane than the terminal parts, however, the interpretation of this
data in terms of accurate distances is difﬁcult as spin diffusion effects
cannot be ruled out [46,73], in particular for such large objects as
peptide/bicelle systems with slow correlation times. Spin diffusion
can take place within the phospholipids, leading to an indirect
saturation transfer to the peptide from a part of the lipid that is not
directly in contact with the saturated lipid moiety. To quantify this
possible effect, we have measured spin diffusion within DMPC by
monitoring the STD signal of the terminal methyl group when the
choline protons were saturated and vice versa. Our data (not shown)
indicate that this saturation transfer is negligible since it is less than
3% of the maximum lipid-peptide saturation transfer. It should be
noted that no peptide-lipid cross peaks could be detected in the 2D
NOESY spectra with mixing times up to 750 ms (data not shown). We
suggest that fast dynamics and longitudinal relaxation during the NOE
mixing time could result in cross peaks too weak to be detected.
3.1.4. Does the membrane environment inﬂuence I583–Y597 structure?
Clearly, the previous interpretation of the STD experiments raises
the question as to what structure this hERG extracellular loop
segment adopts when interacting with the membrane. The structure
of the Ile583–Tyr597 segment, as part of longer hERG segments, has
recently been elucidated in water and SDS micelles by Torres et al.
[26], and in water, DPC and SDS micelles by Jiang et al. [23]. Using CD
and NMR, both studies determined that the hERG S5-P loop was
unstructured in water and formed an α-helix from residues 585 to
593 [26] or an α-helix from residues 583 to 590 and a 310-helix from
positions 591 to 593 [23]. These differences hint to potential structural
changes as a function of the membrane milieu. In order to verify any
particular structural behaviour of the S5-P segment in membranes, CD
studies were carried out with hERG I583–Y597 segment in various
membrane mimetic environments frequently used in membrane
protein structure determination [74]. Negatively charged SDS and
LMPG micelles, zwitterionic DPC, LMPC and DHPC micelles as well as
DMPC/DHPC bicelles were evaluated. LMPC, LMPG and DHPC are the
most lipid-like surfactants [74]. Because a helical structure of the S5-P
segment was reported in SDS micelles, bicelles with 25% (Bicelles/
PS25%) and 50% of negatively charged DMPS were also used to verify
the effect of negative charges on the segment structure.
Our CD results (Fig. 5) clearly demonstrate that the membrane
mimetic environment can inﬂuence the structure of the hERG peptide
I583–Y597. First, an α-helical structure is favoured in SDS (data not
shown), DPC, LMPG and LMPC micelles as suggested by the positive
ellipticity seen between 190 and 195 nm and a negative minimum
at ∼205 and 222 nm. In order to quantify the contributions of different
structural elements, CD spectra were analyzed with the DichroWeb
program [55]. According to this analysis, the hERG peptide would be
57% α-helical in SDS and LMPG, 54% in DPC and 61% in LMPCmicelles.
These results are consistent with previous work published [23,26].
Fig. 5 shows that the hERG loop segment does not adopt a well-
deﬁned structure in water or DHPC micelles. A maximum at ∼225 nm
is seen in the CD spectra of the peptide in water and DHPC micelles.
Because of the presence, in the hERG segment, of a glutamine residue
which can have propensity to adopt a polyproline II conformation, the
possibility of such secondary structure cannot be excluded, albeit the
absence of a negative band centered at ∼205 nm [75]. The CD spectra
measured in bicelles shows a higher residualmolar ellipticity between
190 and 195 nm and a decrease of intensity between 210 and 220 nm
as compared to the pure random coil signature. This could be
attributed to a small proportion of α-helices. These spectra are
therefore not characteristic of a purely unstructured peptide.
DichroWeb deconvolution of I583–Y597 CD spectrum in bicellesindicates an increased contribution of helices (30%), strands (20%)
and turns (20%) while the “unordered” contribution is smaller as
compared to the peptide spectrum recorded in water or DHPC.
Interestingly, spectra obtained in negatively charged bicelles made of
25% DMPS display the characteristic signature of an α-helical
structure. The α-helical content increases to 54% and 65 % for bicelles
comprising 25 and 50 mol% (not shown) of DMPS, respectively.
Because phosphatidylcholines are highly abundant in cardiomyo-
cites [75,76], we have further investigated the structure of the hERG
I583–Y597 segment in zwitterionic DMPC/DHPC bicelles using 2D 1H
NMR experiments. In contrast to surfactant micelles, bicelles display a
planar bilayer region that is similar to that of biomembranes. Hα
secondary chemical shifts can be used as a ﬁrst step for structural
characterization. As was shown by Wishart et al. [77], a negative
deviation of the Hα chemical shift value from random coil values is
indicative of an α-helical structure. Fig. 6A compares the Hα secondary
chemical shifts of the Ile583–Tyr597 in bicelles, SDS micelles and water
obtained from TOCSY spectra. All backbone resonances could be
assigned except HN of Ile583 and Gly584 and Hα resonances of Gly584
an Leu589, possibly due to signal overlap within the peptide or from the
protonated phospholipid headgroups. Virtually all sidechain resonances
(96%) could be assigned (supplementary data). Examination of Fig. 6A
shows that theHα chemical shifts of the hERGsegment in bicelles follow
the same trend as those obtained in SDSmicelles, with similar although
generally smaller deviations from random coil values. Although the Hα
secondary chemical shifts indicate a propensity towards a helical
structure, no contacts indicative of a deﬁned secondary structure could
be detected by 2DNOESY experiments withmixing times up to 250 ms,
as shown in Fig. 6B. Our CD and NMR results indicate that the peptide,
despite adopting anα-helical conformation in strong surfactants suchas
SDSorDPCanddisplayingahelical propensity inbicelles, doesnot adopt
a deﬁned conformation when bound to these model membranes.
3.2. Interaction of cardiotoxic drugs with I583–Y597 and
model membranes
Previous work has demonstrated that drugs such as dofetilide and
vesnarinone can induce LQTS by binding sites on the S5-P extracel-
lular loop of the hERG channel [14,16]. Therefore, we have
investigated the potential role of the central segment I583–Y597 in
Fig. 6. (A) 1Hα secondary chemical shifts from random coil values for hERG I583–Y597 in
H2O at pH 5.5 (grey), bicelles (black) with q=1 and SDS-d25 (white). Unassigned
residues are marked with an asterisk. (B) Table of contacts for hERG I583–Y597 in
bicelles (q=1) obtained by NOESY with a mixing time of 250 ms. The width of the bars
are proportional to cross peak intensities.
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LQTS activity. The structure and logP of bepridil, cetirizine, diphen-
hydramine and pentamidine are shown in Table 1.
Wehaveﬁrst veriﬁed the binding afﬁnity of the cardiotoxic drugswith
the hERG loop segment by self-diffusionmeasurements using by 1HNMR
PFGSTE experiments. As described in a previous section, this method can
be used to detect a binding between LQTS-liable drugs and the hERG
segment studied in thiswork. Table 2 displays the diffusion coefﬁcients of
the drugs, the hERG peptide and one drug, diphenhydramine, in the
presence of the peptide. As can be seen on this Table, the percentages of
drugs associated to I583–Y597 segment vary as follow: bepridil (18%)N
pentamidine (16%)Ncetirizine (13%)Ndiphenhydramine (9%). Note that
these experimentswere conducted at a drug:peptidemolar ratio of 1:1 in
order to force thepotential interactionbetween the two.Wecan therefore
conclude that the binding of the four studied drugs to segment Ile583–
Tyr597 is negligible.
The hERG channel is located in the cardiomyocyte membranes
where the hydrophobic milieu provides the adequate environment to
allow protein movement following gating of the channel [76].
Amphiphilic drugs such as anesthetics are, however, known to affect
cell function by inserting in the membrane bilayer [78]. Considering
the weak afﬁnity for I583–Y597 of the cardiotoxic drugs studied in this
work as well as their amphiphilic nature, we have investigated their
possible interaction with model membranes.
As previously described in this article for segment I583–Y597,
translational diffusion measurements in the presence of isotropic
bicelles (q=0.5) have been carried out to address this question. As
shown in Table 2, the afﬁnity of these drugs for the lipid bilayer isstrong, the fraction of bound molecules varying between 97% and
100%. Consequently, these drugs display a signiﬁcantly higher afﬁnity
for the membrane than for the hERG segment studied in this work.
The 31P and 2H SS-NMR techniques previously described were
used to further investigate the interaction of the cardiotoxics with the
bicelles. As seen in Fig. 7 on the 31P NMR spectra, cetirizine,
diphenhydramine and pentamidine reduce the mosaic spread of the
bicelle orientation in the magnetic ﬁeld [72]. In addition, resonances
of both DMPC and DHPC are shifted upﬁeld when diphenhydramine
and pentamidine are added to the bicelles. This could be explained by
changes in the phospholipid bicelle dynamics [79]. The bicelle
structure is however maintained. The 2H NMR spectra presented in
Fig. 7 for bicelles in the presence of the drugs are typical of well-
oriented objects. Examination of the quadrupolar splittings of DMPC-
d54 shows an increase of 7% in the plateau region when bepridil and
cetirizine are added to the bicelles, and of 4% with diphenhydramine.
No effect is induced by the presence of pentamidine. Altogether, the
SS-NMR data suggest that bepridil, cetirizine and diphenhydramine
would insert in the hydrophobic core of the membrane and induce
some ordering of the lipid acyl chains. On the other hand, pentamidine
would have more afﬁnity for the headgroup region. These results are
consistent with the logP values of the molecules.
This drug afﬁnity for the membrane does not rule out the
possibility of an increased binding of the drug to the peptide when
the latter interacts with the membrane. As shown in previous sections
of this work, the structure of the peptide can be altered in the
presence of the membrane and an eventual membrane-induced
difference in drug peptide interaction needs to be addressed. For this
purpose, diffusion measurements were carried out when the Ile583–
Tyr597 segment is incorporated into isotropic bicelles. We chose to
examine the drug which showed the weakest binding to the free
peptide and the less likely insertion in the hydrophobic core of the
bilayer, namely diphenhydramine.
As revealed in Table 2, a minor increase of the drug binding to the
bicelles is measured when the hERG segment is present, the fraction
of bound diphenhydramine increasing from 96% to 98%. However, this
is within the experimental error, and the strong binding of
diphenhydramine cannot be ascribed to the actual presence of the
I583–Y597 segment. Therefore, we have performed STD experiments in
order to verify any direct interaction of the drug with the hERG
segment in themodel membrane. This was done by saturating speciﬁc
amino acid resonances and monitoring the saturation transferred to
the drug signals. These experiments are known to enable the
detection of transient binding of small ligands (i.e. cardiotoxic
drugs) to macromolecular receptors (i.e. hERG peptide in bicelles)
[44,45]. No saturation transfer to diphenhydramine could be detected
when amide or aromatic protons from the peptide residues were
saturated (data not shown). In consequence, no membrane-induced
direct interaction between the I583–Y597 segment and diphenhydra-
mine could be identiﬁed.
4. Discussion
Efforts have been invested over the past ﬁve years to help reﬁning
the structural model of the hERG channel which is mostly predicted
from homology with other voltage-gated K+ channels. Electrophys-
iology and NMR data provided a better insight on different hERG
moieties such as the N- and C-terminals, S4, S5 and the extracellular
pore loop that links S5 to the pore helix [23,26,80–84]. The dynamical
nature of this segment has been ascertained, and its location in
proximity of the membrane surface motivates the study of an
interaction. In addition, the binding of drugs to the S5-P loop could
trigger long QT effect in the heart. Therefore, the goals of this work
were to study the interaction of the I583–Y597 central segment of the
hERG S5-P loop with model phospholipid membranes, and to
investigate its potential role in ALQTS.
Fig. 7. 31P (left) and 2H (right) SS-NMR spectra of DMPC/DHPC bicelles (q=3.5) at 37 °C in the presence of (A) pentamidine, (B) diphenhydramine, (C) cetirizine and (D) bepridil
(dotted lines) with a drug-to-lipid ratio of 100:1. The reference spectra of bicelles are superimposed for comparison (solid line).
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amenable to both liquid- and solid-state NMR. In addition, their
composition and morphology provide a good mimic of natural
membranes. Lipids are determinants for channel function and their
composition greatly inﬂuences membrane structural and physical
properties, such as curvature and ﬂuidity that are involved in the
regulation of the gating of K+ channels [75,85,86]. Mammalian plasma
membranes are composed of diverse lipids comprising cholesterol,
sphingolipids and phospholipids, with phosphatidylcholines the most
abundant [87]. Furthermore, phospholipids are not symmetrically
distributed within the bilayer of the plasma membrane. Zwitterionic
phosphatidylcholines are more concentrated in the outer leaﬂet while
negatively charged phosphatidylserines are found in the inner leaﬂet
[76]. This further explains the choice of a zwitterionic DMPC/DHPC
bicellar system for our NMR work.
The combination of liquid- and solid-state NMR experiments
showed that the studied hERG segment interacts strongly with the
membrane where it would most likely lie on the surface. This
interaction perturbs the lipid headgroups dynamics and increases the
acyl chain mobility close to the interface. The bilayer integrity is
however preserved. The interaction of the I583–Y597 peptide with the
model membrane is consistent with a “ﬂoppy” outer mouth, as
proposed by Liu et al. [24]. Based on secondary structure analyses and
cysteine-scanning mutagenesis, they demonstrated that the confor-
mational ﬂexibility of the outer mouth plays a key role in the hERGchannel function. This ﬂexibility and signiﬁcant length of the S5-P
linker could allow it to reach the membrane surface where its strong
afﬁnity might allow the stabilization of certain channel conformations
during the gating process [5].
We have then determined the structure of I583–Y597 in zwitterionic
bicelles. This step was important as previous NMR studies were
performed in detergent (SDS and DPC) micelles [23,26]. Our
multidimensional 1H NMR experiments and chemical shift analysis
indicate that the I583–Y597 segment shows no deﬁned secondary
structure. These ﬁndings are conﬁrmed by CD spectroscopy which
also shows that the hERG linker segment is unstructured in water
while it is structured in most of the detergents used in membrane
structure determination, including SDS [74,88]. It thus appears that
the membrane environment strongly inﬂuences the structure of this
hERG loop segment.
Interestingly, the CD spectra of negatively charged bicelles
containing 25% and 50 mol% (not shown) of DMPS display the
characteristic signals of an α-helical structure, and the helical content
increases with surface charge. It is thus clear that the charge of the
model membrane has an effect on the I583–Y597 structure. The
membrane potential in the cardiomyocytes changes rapidly during
the gating process. Therefore, according to our results, we can
hypothesize that this rapid change in surface charge could possibly
result in a modiﬁcation of the conformation of the extracellular
segment (Ile583–Tyr597) of the hERG channel.
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the peptide in DMPC bilayers or in surfactant micelles might be of
functional importance. Torres et al. [26] and Jiang et al. [23] have shown,
using electrophysiology experiments, that the S5-P linker interactswith
other parts of the channel. It is thus possible that hydrophobic regions of
the hERG channel might provide an additional driving force that would
enable the structuring of the region fromW585 to I593, the segment that
has been shown to adopt an alpha helical conformation is SDS or DPC
micelles [23,26]. According to our results, an interaction with the
membrane bilayer would not be sufﬁcient for this segment to adopt a
helical structure. Thus, should the functional structure of W585–I593
actually be an alpha-helix, it would result from protein-protein
interactions rather than protein-membrane interactions. For lack of
structural data on the complete hERG pore in a membrane milieu, the
question of the in vivo structure of segment I583–Y597 remains open.
Considering the structural ﬂexibility of the S5-P linker, a model in
which segment I583–Y597 would bind competitively (or at different
stages of the gating process) to other parts of the pore channel or the
membrane can be hypothesized. The concomitant structural changes
could provide additional conformational ﬂexibility to the outer mouth
region. This is consistent with the role of the extracellular pore loops
in the pore domain of ion channels, i.e. to provide architectural
versatility [5].
The results obtained by 1H NMR diffusion experiments show that
the four hERG-active drugs studied in this work have a weak afﬁnity
for the I583–Y597 segment. The experiments were done at a drug/
peptide molar ratio of 1:1, well above what could be expected
biologically. This segment would, thus, most likely not be targeted by
bepridil, cetirizine, diphenhydramine and pentamidine in the ALQTS
mechanism. Previous studies on bepridil suggest that this antiangine
medicine would bind sites close to the pore helix (Thr623, Ser624, and
Val625) and Phe656 on S6. However, these drugs showed a marked
afﬁnity for the membrane environment of the hERG channel. It is thus
conceivable that the partition of these drugs in the membrane could
change its local properties, thus affecting the channel function. For
example, voltage-gated K+ channels such as the Shaker are known to
be mechanosensitive and can respond to membrane stretch [76].
Therefore the movement of VGK channels during the gating can be
altered by the lipid-protein interface [76]. Studies have shown that
the conformation of channels such as the MscL can be changed by
deformation of the lipid bilayer [89]. The lipid annulus composition
around membrane proteins such as ion channels plays a role in its
conformation and could be involved in triggering events [86].
Therefore, perturbation of this annular shell by drugs is a possible
drug action mechanism as suspected with anaesthetics [90]. A similar
mechanism of action has been evidenced with the voltage-sensor
toxin VsTx1 with the Kv2.1 channel [91]. Finally, the QT prolongation
induced by these drugs would most likely be explained by a
preference for other binding sites on other hERG domains. They
could, for example, traverse the membrane to access putative LQTS-
provoking target residues which lie in the cytosolic (intracellular)
parts of the hERG channel, as was observed for tetracaine which
interaction with membrane lipids enhanced its access to the
transmembrane pore [92]. Therefore, our drug–membrane interaction
results open the possibility of a membrane catalysis model for drugs
involved in the ALQTS, as can be observed for receptor ligands [93].
5. Conclusion
Using a liquid- and solid-state NMR approach, we have shown that
extracellular S5-P linker segment I583–Y597 of the hERG channel
strongly interacts with model PC membranes where it would rest in
the polar region. This segment does not adopt a well-deﬁned
secondary structure despite its strong interaction with this speciﬁc
membrane bilayer, as conﬁrmed by circular dichroism analysis. Its
conformation, however, was shown to vary as a function of themembrane nature and charge, thus proving its strong structural
ﬂexibility. These results show that the membrane is likely to play an
important role in hERG channel functioning, possibly by stabilizing
transient conformations during the gating process. The interaction
with this hERG segment of four cardiotoxic drugs, namely bepridil,
cetirizine, diphenhydramine and pentamidine, was shown to be
negligible. However, these drugs proved to have a strong afﬁnity for
the membrane, thus opening the possibility for a membrane-
mediated ALQTS mechanism or membrane catalysis.Acknowledgments
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